Sort by
Refine Your Search
-
Country
-
Program
-
Employer
-
Field
-
Therapy Accelerator The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), have invested a total of £30m over 4 years through the Strategic Priorities Fund to establish a nucleic
-
the UK Medical Research Council and is available immediately. The salary will be on the Academic Pathway salary scale, Grade 6 in the range £43,947-£49,908 per annum (inclusive of London Weighting
-
Therapy Accelerator The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), have invested a total of £30m over 4 years through the Strategic Priorities Fund to establish a nucleic
-
Medical Research Council Lifecourse Epidemiology Unit Location: Southampton General Hospital Salary: £32,398 to £55,329 per annum Full Time Fixed Term for 2 years Closing Date: Friday 24 May 2024
-
this project will directly work with research teams developing and testing new vaccines. The Medical Research Council (MRC) Centre for Global Infectious Disease Analysis is an international resource and centre
-
About the job: The postholder will deliver the exciting project funded by UK Medical Research Council which involves process development of extracellular vesicles-based therapy manufacturing as
-
laboratory is multidisciplinary and international, with sustained high-quality productivity. Our work is generously supported by funding from the Medical Research Council, and an ERC Advanced Grant to the PI
-
Accelerator The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), have invested a total of £30m over 4 years through the Strategic Priorities Fund to establish a nucleic acid therapy
-
Nucleic Acid Therapy Accelerator The Medical Research Council (MRC), as part of UK Research and Innovation (UKRI), have invested a total of £30m over 4 years through the Strategic Priorities Fund
-
the first instance and is funded by the Wellcome and Medical Research Council. Only applications received before 12 midday on Friday 17 May 2024 will be considered. Please quote 172286 on all correspondence.